Logo image of JPI

NUVEEN PREFERRED SECURITIES (JPI) Stock Price, Quote, News and Overview

NYSE:JPI - New York Stock Exchange, Inc. - US67075A1060 - Currency: USD

19.86  -0.09 (-0.45%)

Fundamental Rating

1

Taking everything into account, JPI scores 1 out of 10 in our fundamental rating. JPI was compared to 0 industry peers in the Unkown industry. JPI has a bad profitability rating. Also its financial health evaluation is rather negative. JPI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

JPI had negative earnings in the past year.
JPI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: JPI reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: JPI reported negative operating cash flow in multiple years.
JPI Yearly Net Income VS EBIT VS OCF VS FCFJPI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M

1.2 Ratios

Industry RankSector Rank
ROA -4.93%
ROE -7.87%
ROIC 3.11%
ROA(3y)-0.3%
ROA(5y)0.49%
ROE(3y)-0.72%
ROE(5y)0.57%
ROIC(3y)3.4%
ROIC(5y)3.49%
JPI Yearly ROA, ROE, ROICJPI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10 15

1.3 Margins

JPI's Operating Margin has declined in the last couple of years.
JPI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 57.68%
PM (TTM) N/A
GM 57.95%
OM growth 3Y-8.09%
OM growth 5Y-5.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y-5.05%
JPI Yearly Profit, Operating, Gross MarginsJPI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, JPI has about the same amount of shares outstanding.
JPI has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for JPI is higher compared to a year ago.
JPI Yearly Shares OutstandingJPI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
JPI Yearly Total Debt VS Total AssetsJPI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

JPI has an Altman-Z score of 1.64. This is a bad value and indicates that JPI is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of JPI is 3.65, which is a good value as it means it would take JPI, 3.65 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.59 indicates that JPI is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 3.65
Altman-Z 1.64
ROIC/WACCN/A
WACCN/A
JPI Yearly LT Debt VS Equity VS FCFJPI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

A Current Ratio of 0.18 indicates that JPI may have some problems paying its short term obligations.
A Quick Ratio of 0.18 indicates that JPI may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.18
JPI Yearly Current Assets VS Current LiabilitesJPI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 83.99% over the past year.
JPI shows a decrease in Revenue. In the last year, the revenue decreased by -4.25%.
The Revenue has been decreasing by -2.12% on average over the past years.
EPS 1Y (TTM)83.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%298.72%
Revenue 1Y (TTM)-4.25%
Revenue growth 3Y-2.17%
Revenue growth 5Y-2.12%
Sales Q2Q%-2.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JPI Yearly Revenue VS EstimatesJPI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

0

4. Valuation

4.1 Price/Earnings Ratio

JPI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JPI Price Earnings VS Forward Price EarningsJPI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 4.14
EV/EBITDA N/A
JPI Per share dataJPI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

JPI has a Yearly Dividend Yield of 8.17%, which is a nice return.
JPI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.47.
Industry RankSector Rank
Dividend Yield 8.17%

5.2 History

The dividend of JPI decreases each year by -3.68%.
JPI has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of JPI decreased recently.
Dividend Growth(5Y)-3.68%
Div Incr Years1
Div Non Decr Years1
JPI Yearly Dividends per shareJPI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

The earnings of JPI are negative and hence is the payout ratio. JPI will probably not be able to sustain this dividend level.
DP-96.64%
EPS Next 2YN/A
EPS Next 3YN/A
JPI Yearly Income VS Free CF VS DividendJPI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M

NUVEEN PREFERRED SECURITIES

NYSE:JPI (4/25/2025, 8:18:58 PM)

19.86

-0.09 (-0.45%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners8.84%
Inst Owner Change-42.24%
Ins OwnersN/A
Ins Owner Change0%
Market Cap280.22M
Analysts0
Price TargetN/A
Short Float %0.03%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield 8.17%
Yearly Dividend1.4
Dividend Growth(5Y)-3.68%
DP-96.64%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-15 2025-04-15 (0.166)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.16
P/FCF 4.14
P/OCF 4.14
P/B 0.67
P/tB 0.67
EV/EBITDA N/A
EPS(TTM)-0.29
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.8
FCFY24.17%
OCF(TTM)4.8
OCFY24.17%
SpS3.22
BVpS29.77
TBVpS29.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.93%
ROE -7.87%
ROCE 4.37%
ROIC 3.11%
ROICexc 3.11%
ROICexgc 3.11%
OM 57.68%
PM (TTM) N/A
GM 57.95%
FCFM 148.89%
ROA(3y)-0.3%
ROA(5y)0.49%
ROE(3y)-0.72%
ROE(5y)0.57%
ROIC(3y)3.4%
ROIC(5y)3.49%
ROICexc(3y)3.4%
ROICexc(5y)3.49%
ROICexgc(3y)3.41%
ROICexgc(5y)3.5%
ROCE(3y)4.7%
ROCE(5y)4.78%
ROICexcg growth 3Y-5.87%
ROICexcg growth 5Y-4.17%
ROICexc growth 3Y-5.82%
ROICexc growth 5Y-4.08%
OM growth 3Y-8.09%
OM growth 5Y-5.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y-5.05%
F-Score6
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 3.65
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.15
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.18
Altman-Z 1.64
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%298.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.25%
Revenue growth 3Y-2.17%
Revenue growth 5Y-2.12%
Sales Q2Q%-2.82%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.21%
EBIT growth 3Y-10.08%
EBIT growth 5Y-7.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.14%
FCF growth 3Y2.73%
FCF growth 5Y11.83%
OCF growth 1Y59.14%
OCF growth 3Y2.73%
OCF growth 5Y11.83%